From weekend runners nursing a sprained ankle to patients recovering from a knee replacement, orthopedic braces and supports sit at the center of modern musculoskeletal care. As non-invasive treatment, faster rehabilitation and preventive care gain ground, this once-conventional category is becoming a hotbed of technology and strategic activity. Here is what the numbers say, where the innovation is happening, and what could hold manufacturers back.

Market Overview & Key Statistics

According to Grand View Research, the global orthopedic braces and supports market was valued at USD 4.9 billion in 2025 and is estimated at USD 5.2 billion in 2026. It is projected to reach USD 8.1 billion by 2033, expanding at a CAGR of 6.5% from 2026 to 2033.

Key figures at a glance

• Product leader: The braces and supports type segment (knee, back, ankle, upper extremity, hip braces and walking boots) held a 74.5% revenue share in 2025.
• End-use leader: Orthopedic clinics accounted for the largest share at 30.0% in 2025, while over-the-counter (OTC) channels are expected to grow fastest.
• Regional leader: North America led with a 33.4% revenue share in 2025, with the U.S. the largest national market.
• Fastest-growing region: Asia Pacific is expected to post the highest CAGR through 2033.

What is driving growth?

Several forces are working together. An aging population is increasing the burden of osteoarthritis and mobility problems. Participation in sports and fitness is rising, and so are injuries: the report notes that ACL tears climbed 12% between the 2007-08 and 2021-22 seasons. Orthopedic surgical volumes are also expanding. The American Joint Replacement Registry reported more than 4 million hip and knee arthroplasty procedures in its database as of March 2024, an 18% year-over-year increase. Since more procedures are shifting to outpatient and ambulatory settings, patients need dependable braces for recovery at home.

Ready to explore the data behind these insights? Get a free sample with market data points, trend analyses, estimates and forecasts, and see how the full report is structured. Download a Free Sample

Technical Innovations

Personalized, digitally fabricated bracing. 3D scanning, 3D printing, intelligent design software and new biomaterials are making custom-fit alternatives to traditional casts and off-the-shelf supports a commercial reality. In April 2025, Dimension Ortho partnered with Rothman Orthopaedics to roll out its personalized bracing and fracture care platform across Rothman’s clinical network, a sign of growing provider appetite for this model.

Smarter, lighter, more comfortable designs. Lightweight materials, adjustable fit systems and ergonomic construction improve comfort, and comfort improves compliance, which directly affects recovery outcomes. Grand View Research’s analyst perspective also points to digital monitoring capabilities as a way to boost treatment adherence and deepen clinician engagement.

Condition-specific product launches. Manufacturers are targeting defined clinical needs:

• Enovis launched the DonJoy ROAM OA knee brace in January 2024, built to offload the affected knee compartment for people with osteoarthritis, pain and instability.
• OrthoPediatrics introduced its Specialty Bracing division in December 2023 and the DF2 Brace for young femur fracture patients in October 2023.
• Dr. Brace released a knee compression sleeve in October 2024 featuring 360-degree compression and side stabilizers.

Custom research delivered alongside the report also highlights smart braces, sensor-enabled monitoring and composite materials as areas where technology benchmarking is shaping competitive positioning.

Need expert guidance on the orthopedic braces and supports market? Our analysts can help you interpret regional trends, competitive dynamics and growth opportunities for your strategy. Speak to an Analyst

Competitive Landscape & Strategic Headwinds

Who is competing?

The field includes BREG, Össur, DeRoyal Industries, DJO (Enovis), Ottobock, Bauerfeind, Fillauer, Frank Stubbs Company, Weber Orthopedic, McDavid, 3M and Zimmer Biomet. Established players such as Ottobock and DJO compete through broad portfolios, strong R&D, extensive distribution and long-standing relationships with providers and reimbursement networks. Their trade-offs are higher operating costs, complex regulatory obligations and slower reaction to niche demand. Emerging players such as Fillauer lean on flexibility, customization, direct-to-consumer channels and clinician engagement, but face limited global reach and thinner resources.

How companies are responding

• Acquisitions: OrthoPediatrics acquired Boston Orthotics & Prosthetics in January 2024. Aspen Medical Products bought Advanced Orthopaedics in January 2025 to extend beyond spinal care. Enovis acquired LimaCorporate in January 2024.
• Partnerships and distribution: Breg teamed up with an Australian distributor to bring premium products to that market, and Ultra Ankle partnered with Tandem Sport to tap North American volleyball.
• Regional capacity: Tynor Orthotics invested Rs 800 crore in an orthopedic manufacturing facility in Punjab, India, reflecting the Asia Pacific opportunity.

Strategic headwinds

1. Reimbursement gaps. Braces are often classed as durable medical equipment or semi-essential devices, leading to partial or no coverage, particularly for advanced or customized products. Higher out-of-pocket costs can limit adoption in price-sensitive and emerging markets.
2. Pricing pressure. Payers and health systems are steering procurement toward low-cost, generic designs. Intense price competition squeezes margins and can discourage investment in premium innovation.
3. Regulatory burden. The EU’s medical device regulation, which covers braces, demands a rigorous approval process and strict post-market surveillance. Evolving frameworks elsewhere, such as in South Africa, can delay product approvals.
4. Uneven regional infrastructure. In the Middle East and Africa, inconsistent reimbursement and limited local manufacturing capacity remain obstacles despite rising demand.

The takeaway: the winners are likely to be companies that combine product innovation with digital monitoring, clinician engagement and patient support programs, covering everything from injury prevention to post-operative recovery and chronic condition management.

Looking Ahead

With steady 6.5% growth, expanding surgical volumes and technology reshaping how braces are designed and delivered, the market offers real opportunity for those who can navigate reimbursement, pricing and regulatory hurdles. The full report adds regional and country-level forecasts across 23 countries, segment data from 2021 to 2033, and profiles of key players.

Explore our dedicated business services:

Prism AI: Market Intelligence with Cited Research- Ask questions in plain language and get insights drawn from Grand View Research's entire research library, with sources cited. Create your free account today.

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today